MYOM2 and COVID-19: The aim of this study was to test sera from COVID-19 patients against glycosylated, deglycosylated, and unglycosylated RBDs and M-proteins to assess the relevance of protein N-glycosylation for antibody recognition and to test whether bacterial expression systems would be sufficient for RBD and M-protein expression.